TY - JOUR
T1 - Arthritis gene therapy is becoming a reality
AU - Evans, Christopher H.
AU - Ghivizzani, Steven C.
AU - Robbins, Paul D.
N1 - Funding Information:
The work of C.H.E., S.C.G. and P.D.R. in this area has been funded by multiple grants from the National Institute of Arthritis and Musculoskeletal Skin Diseases (NIAMS) and the National Institute on Aging (NIA) and the US Department of Defense.
Copyright:
Copyright 2018 Elsevier B.V., All rights reserved.
PY - 2018/7/1
Y1 - 2018/7/1
N2 - After more than 25 years of development, arthritis gene therapy is finally entering clinical practice. In South Korea, a gene therapeutic has been approved for the treatment of osteoarthritis, and other gene therapeutics are in the pipeline elsewhere. Genetic medicines for arthritis should enter the rheumatological armamentarium in the foreseeable future.
AB - After more than 25 years of development, arthritis gene therapy is finally entering clinical practice. In South Korea, a gene therapeutic has been approved for the treatment of osteoarthritis, and other gene therapeutics are in the pipeline elsewhere. Genetic medicines for arthritis should enter the rheumatological armamentarium in the foreseeable future.
UR - http://www.scopus.com/inward/record.url?scp=85046810426&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85046810426&partnerID=8YFLogxK
U2 - 10.1038/s41584-018-0009-5
DO - 10.1038/s41584-018-0009-5
M3 - Comment/debate
C2 - 29743627
AN - SCOPUS:85046810426
SN - 1759-4790
VL - 14
SP - 381
EP - 382
JO - Nature Reviews Rheumatology
JF - Nature Reviews Rheumatology
IS - 7
ER -